Erlotinib
Erlotinib

Erlotinib

Catalog NumberPI183321746

CAS Number183321-74-6

CategoryAntineoplastic Agents

Erlotinib is a selective inhibitor of tyrosine kinase that prevents signal transmission of important growth factors. This stops tumor growth. Erlotinib was approved in the EU in 2005 and in 2007 the indication of non-small cell bronchial carcinoma was extended to include the treatment of pancreatic cancer.
Erlotinib

* Our products are for research use only.

Get in Touch

We're glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2